Comparative Pharmacology
Head-to-head clinical analysis: METHADOSE versus OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHADOSE versus OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN.
METHADOSE vs OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methadone is a mu-opioid receptor agonist; it also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake, contributing to its analgesic and detoxification effects. It has a long half-life and reduces opioid craving and withdrawal symptoms.
Oxycodone is a mu-opioid receptor agonist, inhibiting neurotransmitter release and pain signal transmission. Acetaminophen inhibits cyclooxygenase (COX) enzymes, particularly in the central nervous system, reducing prostaglandin synthesis and pain perception.
Oral: 20-40 mg once daily, titrated to effect; for opioid dependence, typical maintenance 80-120 mg/day. IV: 2.5-10 mg every 8-12 hours.
Adults: 1-2 tablets (each containing 5 mg oxycodone/325 mg acetaminophen) orally every 4-6 hours as needed for pain; maximum 12 tablets per day (60 mg oxycodone/3900 mg acetaminophen).
None Documented
None Documented
Terminal elimination half-life range: 8–59 hours (mean ~20–35 hours). In chronic use, half-life may increase due to accumulation. Context: The long half-life supports once-daily dosing for opioid dependence but requires careful titration to avoid accumulation.
Oxycodone: 3.5-5.5 hours (immediate-release); Acetaminophen: 1.5-3 hours. Clinical context: renal/hepatic impairment prolongs half-life.
Primarily renal (approximately 80%) as inactive metabolites, with about 20% eliminated via feces. Less than 10% excreted unchanged.
Oxycodone: primarily renal (10-20% unchanged, metabolites conjugated); Acetaminophen: renal (85-90%, primarily as glucuronide and sulfate conjugates, <5% unchanged).
Category C
Category D/X
Opioid Agonist
Opioid Agonist